PUBLISHER: KBV Research | PRODUCT CODE: 1462071
PUBLISHER: KBV Research | PRODUCT CODE: 1462071
North America Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Country and Growth Forecast, 2023 - 2030
The North America Iliac Stent Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).
The US market dominated the North America Others Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.7 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).
Iliac stent procedures stand at the forefront of innovation, revolutionizing the treatment landscape for patients with the disease. The adoption trends in the market reflect a dynamic interplay of technological innovation, clinical evidence, regulatory considerations, and healthcare economics, shaping patterns of utilization and market dynamics.
Next-generation stent platforms offer improved radial strength, flexibility, and conformability, allowing for precise placement and optimal lesion coverage in challenging anatomies. Moreover, innovations in drug-eluting stents, bioresorbable stents, and surface-modified coatings aim to enhance patency rates, reduce restenosis, and improve long-term outcomes, driving the adoption of advanced stent technologies.
Canada has a high rate of vehicular accidents, which has raised demand for medical procedures such as the implantation of iliac stents to treat vascular problems and traumatic injuries. According to the Canadian government, in 2021, motor vehicle fatalities totalled 1,768, representing an increase of 1.3% compared to the 2020 figure of 1,746. Additionally, serious injuries from motor vehicle accidents rose by 4% to 8,185, while the total number of injuries increased by 3.6% to 1,08,018. Therefore, the increasing road traffic injuries and rapid urbanization in the region propel the market's growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
North America Iliac Stent Market Report Segmentation
By Artery Lesions
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
By End-use
- Hospitals
- Outpatient Facilities
- Others
By Type
- Self-expandable Stents
- Balloon-expandable Stents
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Iliac Stent Market, by Artery Lesions
- 1.4.2North America Iliac Stent Market, by End-use
- 1.4.3North America Iliac Stent Market, by Type
- 1.4.4North America Iliac Stent Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.North America Iliac Stent Market by Artery Lesions
- 4.1North America Common Iliac Artery Lesions Market by Country
- 4.2North America Severe Calcified Lesions Market by Country
- 4.3North America Complete Obstructive Lesions Market by Country
Chapter 5.North America Iliac Stent Market by End-use
- 5.1North America Hospitals Market by Country
- 5.2North America Outpatient Facilities Market by Country
- 5.3North America Others Market by Country
Chapter 6.North America Iliac Stent Market by Type
- 6.1North America Self-expandable Stents Market by Country
- 6.2North America Balloon-expandable Stents Market by Country
- 6.3North America Others Market by Country
Chapter 7.North America Iliac Stent Market by Country
- 7.1US Iliac Stent Market
- 7.1.1US Iliac Stent Market by Artery Lesions
- 7.1.2US Iliac Stent Market by End-use
- 7.1.3US Iliac Stent Market by Type
- 7.2Canada Iliac Stent Market
- 7.2.1Canada Iliac Stent Market by Artery Lesions
- 7.2.2Canada Iliac Stent Market by End-use
- 7.2.3Canada Iliac Stent Market by Type
- 7.3Mexico Iliac Stent Market
- 7.3.1Mexico Iliac Stent Market by Artery Lesions
- 7.3.2Mexico Iliac Stent Market by End-use
- 7.3.3Mexico Iliac Stent Market by Type
- 7.4Rest of North America Iliac Stent Market
- 7.4.1Rest of North America Iliac Stent Market by Artery Lesions
- 7.4.2Rest of North America Iliac Stent Market by End-use
- 7.4.3Rest of North America Iliac Stent Market by Type
Chapter 8.Company Profiles
- 8.1Becton, Dickinson, and Company
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
- 8.1.5.1Trials and Approvals:
- 8.1.6SWOT Analysis
- 8.2Abbott Laboratories
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
- 8.3Boston Scientific Corporation
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
- 8.3.5.1Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4W. L. Gore & Associates, Inc.
- 8.4.1Company Overview
- 8.4.2SWOT Analysis
- 8.5Medtronic PLC
- 8.5.1Company overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5Recent strategies and developments:
- 8.5.5.1Trials and Approvals:
- 8.5.6SWOT Analysis
- 8.6Cook Medical, Inc. (Cook Group)
- 8.6.1Company Overview
- 8.6.2SWOT Analysis
- 8.7Terumo Corporation
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Trials and Approvals:
- 8.7.5.2Product Launches and Product Expansions:
- 8.7.6SWOT Analysis
- 8.8iVascular S.L.U.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Getinge AB
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expense
- 8.9.5Recent strategies and developments:
- 8.9.5.1Trials and Approvals:
- 8.9.6SWOT Analysis
- 8.10.Biotronik SE & Co. KG
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1North America Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 2North America Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 3North America Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 4North America Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 5North America Common Iliac Artery Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 6North America Common Iliac Artery Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 7North America Severe Calcified Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 8North America Severe Calcified Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 9North America Complete Obstructive Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 10North America Complete Obstructive Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 11North America Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 12North America Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 13North America Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 14North America Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 15North America Outpatient Facilities Market by Country, 2019 - 2022, USD Million
- TABLE 16North America Outpatient Facilities Market by Country, 2023 - 2030, USD Million
- TABLE 17North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 18North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 19North America Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 20North America Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 21North America Self-expandable Stents Market by Country, 2019 - 2022, USD Million
- TABLE 22North America Self-expandable Stents Market by Country, 2023 - 2030, USD Million
- TABLE 23North America Balloon-expandable Stents Market by Country, 2019 - 2022, USD Million
- TABLE 24North America Balloon-expandable Stents Market by Country, 2023 - 2030, USD Million
- TABLE 25North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 26North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 27North America Iliac Stent Market by Country, 2019 - 2022, USD Million
- TABLE 28North America Iliac Stent Market by Country, 2023 - 2030, USD Million
- TABLE 29US Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 30US Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 31US Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 32US Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 33US Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 34US Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 35US Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 36US Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 37Canada Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 38Canada Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 39Canada Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 40Canada Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 41Canada Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 42Canada Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 43Canada Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 44Canada Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 45Mexico Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 46Mexico Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 47Mexico Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 48Mexico Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 49Mexico Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 50Mexico Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 51Mexico Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 52Mexico Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 53Rest of North America Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 54Rest of North America Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 55Rest of North America Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 56Rest of North America Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 57Rest of North America Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 58Rest of North America Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 59Rest of North America Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 60Rest of North America Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 61Key Information - Becton, Dickinson and Company
- TABLE 62Key Information - Abbott Laboratories
- TABLE 63Key Information - Boston Scientific Corporation
- TABLE 64Key Information - W. L. Gore & Associates, Inc.
- TABLE 65Key Information - Medtronic PLC
- TABLE 66Key Information - Cook Medical, Inc.
- TABLE 67Key Information - Terumo Corporation
- TABLE 68Key Information - iVascular S.L.U.
- TABLE 69Key Information - Getinge AB
- TABLE 70Key Information - Biotronik SE & Co. KG
